# US 2017/0254777 A1 · Method to improve the identification, quantification and spatial localization of multiply charged molecules in biological samples using ion mobility information

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0254777 A1
- Document ID: US20170254777A1
- Status: Published application
- Kind: A1
- Application number: 15/435,748
- Filed: 2017-02-17
- Published: 2017-09-07
- Earliest claimed: 2016-02-18
- Assignees: Waters Technologies Corporation
- Applicants: Waters Technologies Corporation
- Inventors: Hernando Olivos; Giuseppe Astarita
- Web page: https://patentgrep.com/patent/US20170254777A1

## CPC

- G01N 27/623: combined with mass spectrometry
- G01N 30/72: Mass spectrometers {(mass spectrometers per se H01J49/00)}
- G01N 30/7233: {interfaced to liquid or supercritical fluid chromatograph (interfaces in general for introducing or extracting samples to be analysed with specially adapted mass spectrometer, see H01J49/04)}
- H01J 49/004: {Combinations of spectrometers, tandem spectrometers, e.g. MS/MS, MSn}
- H01J 49/165: {Electrospray ionisation}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- H01J: ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS (spark-gaps H01T; electric arc lamps H05B31/00; particle accelerators H05H)

## Abstract

Described herein is a method of analyzing a sample including molecules having two or more possible sites for ionization comprising: 1) separating ionized molecules of the sample according to ion mobility of the ionized molecules, and 2) analyzing the ionized molecules using mass spectrometry. Additionally described herein is a method of diagnosing and/or determining the progression of a disease or disorder associated with gangliosides and/or cardiolipins in a subject comprising: 1) separating ionized molecules in a biological sample from the subject according to ion mobility of the ionized molecules, and 2) analyzing the ionized molecules using mass spectrometry to identify and quantify gangliosides and/or cardiolipins in the sample.

## Claims

### Claim 1

A method of analyzing a sample including lipids having two or more possible sites for ionization comprising:
1) separating ionized molecules of the sample according to ion mobility of the ionized molecules, and
2) analyzing the ionized molecules using mass spectrometry.

### Claim 2 (depends on 1)

The method of claim 1, wherein the ionized molecules are separated according to ion mobility based on the charge state of the ionized molecules.

### Claim 3 (depends on 1)

The method of claim 1, wherein the lipid is a gangliosides or a cardiolipins.

### Claim 4 (depends on 1)

The method of claim 1 wherein the ion mobility-based separation includes drift-time ion mobility spectrometry, travelling-wave ion mobility spectrometry, or differential mobility spectrometry.

### Claim 5 (depends on 1)

The method of claim 1, further comprising an ionization step, wherein the ionization includes electrospray ionization (ESI) or a desorption ionization technique.

### Claim 6 (depends on 5)

The method of claim 5, wherein the ionization step includes electrospray ionization.

### Claim 7 (depends on 1)

The method of claim 1, further comprising a step of separating the molecules using chromatography.

### Claim 8 (depends on 7)

The method of claim 7, wherein the chromatography includes liquid chromatography or gas chromatography (GC).

### Claim 9 (depends on 8)

The method of claim 8, wherein the liquid chromatography is selected from ultra high performance liquid chromatography (UHPLC), high performance liquid chromatography (HPLC), hydrophilic interaction chromatography (HILIC), and supercritical fluid chromatography (SFC)

### Claim 10 (depends on 9)

The method of claim 9, wherein the chromatography step occurs prior to the separation of ions based on their ion mobility.

### Claim 11 (depends on 1)

The method of claim 1, further comprising sampling a plurality of different locations on the sample and obtaining mass spectral data corresponding to each location.

### Claim 12 (depends on 11)

The method of claim 11, wherein the sample is a tissue section or a cell culture.

### Claim 13 (depends on 1)

The method of claim 1, wherein the sample is plasma.

### Claim 14 (depends on 13)

The method of claim 13, wherein the sample is a dried blood spot.

### Claim 15 (depends on 11)

The method of claim 11, wherein the sampling at a plurality of different locations provides spatial location information for molecules in the sample.

### Claim 16 (depends on 1)

The method of claim 1, wherein the mass spectrometry includes tandem mass spectrometry (MS/MS).

### Claim 17 (depends on 1)

The method of claim 1, further comprising calculating a collisional cross section (CCS) in the identification of components of the sample.

### Claim 18 (depends on 1)

The method of claim 1, wherein the sample is infused directly into the instrument used for ion mobility-based separation.

### Claim 19 (depends on 1)

The method of claim 1, wherein the sample includes one or more isobaric lipids and the ion mobility step separates lipids having two or more possible sites for ionization.

### Claim 20

A method of diagnosing or determining the progression of a disease or disorder associated with gangliosides or cardiolipins in a subject comprising separating ionized molecules in a biological sample from the subject according to ion mobility of the ionized molecules, and analyzing the ionized molecules using mass spectrometry to identify and quantify gangliosides or cardiolipins in the sample.

### Claim at position 21

21-37. (canceled)
